Longitudinal Assessment of Cardiovascular and Renal Health in Patients With Hepatitis-C (CARE-Hep C)
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 01 Mar 2017
At a glance
- Drugs BMS 986094 (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- Acronyms CARE-HepC
- 12 Mar 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 09 May 2014 Planned number of patients changed from 500 to 160 as reported by ClinicalTrials.gov.
- 10 May 2013 New trial record